Soon after a June 2020 laboratory-based Australian study showed that the anti-parasitic drug can block replication of the coronavirus in a laboratory setting, sales of ivermectin went through the roof. In Brazil alone, 12 million packages of ivermectin ...
VIEW MORE : https://bit.ly/1breakingnews
